Evosep at IMSC 2026

We are thrilled to once again participate at the annual International Mass Spectrometry Conference (IMSC), which will take place in Lyon, France. Please visit us at our booth #2, where will be happy to introduce you to our technology and how we can contribute with fully automated and standardized workflows. You are also welcome to join our Evosep Lunch symposium, register and secure your seat now.

See our activities at this year’s IMSC 2026.

Tuesday, August 25, 2026: 12:45 – 13:45 – Room Salon Tête d’Or

IMSC 2026 lunch symposium – Standardizing High-throughput LC-MS based proteomics for actionable insights

Join us for lunch and get the newest data of proteomics workflows, scientific discussions, and new discoveries from Evosep.
Learn more about the full programme at IMSC 2026

Tuesday, August 25, 2026: 12:45 – 13:45

Room Salon Tête d’Or

IMSC 2026 lunch symposium – Standardizing High-throughput LC-MS based proteomics for actionable insights

Join us for lunch and get the newest data of proteomics workflows, scientific discussions, and new discoveries from Evosep.
Learn more about the full programme at IMSC 2026

Meeting Diverse Study Demands with Standardized LC-MS: A Core Facility Perspective

Talk by Erik Soderblom, Director, Proteomics and Metabolomics Core Facility at Duke University

As the analytical power of modern mass spectrometry based proteomics continues to evolve, so does the breath of biological questions the technology is able to support. This is particularly evident in a Mass Spectrometry Core Facility environment tasked with answering an increasingly wide range of basic science and biomedical questions, each with their own unique set of study goals and related challenges.

To accommodate these challenges while maintaining high data quality, we will discuss the importance of LC-MS standardization in the context of study-specific throughput and sensitivity requirements. EvoSep’s role in this standardization in our Core Facility will be discussed in two very different use cases: 1. in-vivo spatially-directed proteomic studies within neuronal synapses of various mouse models and 2. a large-scale biomarker discovery study of osteoarthritis progression from thousands of human plasma samples. Unique challenges inherent to these studies as well as experimental design and LC-MS based considerations to maintain consistently high quality data will be presented.

Introducing Evosep Proteomics for scalable and standardized LC-MS

Talk by Maurine Fucito, PhD., Field Application Specialist at Evosep

Scalable proteomics depends on standardized LC-MS workflows that minimize variability from sample preparation to data acquisition while remaining robust across instruments and throughput demands. Evosep Proteomics addresses this challenge with an integrated ecosystem combining automated sample preparation, built-in quality controls, and standardized chromatography to deliver reproducible, end-to-end proteomics workflows for mass spectrometry. By reducing workflow variability at the source, the platform enables consistent performance and streamlines the transition from discovery to targeted proteomics.

To assess robustness and transferability, two Evokits were processed on two independent Evosep Lupo systems using 1 µg of K562 lysate. The workflow delivered highly consistent digestion efficiencies of ~80% across plates, identified more than 6,000 proteins at 500 samples per day (SPD) with 92% overlap between runs, and achieved protein-level CVs of ~12%. These results demonstrate low variability across the complete workflow, including sample preparation, chromatography, and MS analysis, highlighting excellent inter-system reproducibility. Together, these findings demonstrate how workflow standardization can transform proteomics into a scalable and reproducible analytical platform, enabling confident biological insights across laboratories, instruments, and studies.